Compare TK & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | INMD |
|---|---|---|
| Founded | 1973 | 2008 |
| Country | Bermuda | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 925.8M | 842.0M |
| IPO Year | 1995 | 2018 |
| Metric | TK | INMD |
|---|---|---|
| Price | $11.27 | $15.33 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.33 |
| AVG Volume (30 Days) | 513.5K | ★ 597.4K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 15.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | $13.43 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.34 | $12.72 |
| 52 Week High | $14.38 | $16.74 |
| Indicator | TK | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 52.71 |
| Support Level | $11.25 | $14.94 |
| Resistance Level | $12.50 | $15.23 |
| Average True Range (ATR) | 0.41 | 0.25 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 49.58 | 27.27 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.